Fund Holdings — MPM ASSET MANAGEMENT LLC

Total Portfolio Value:
$203.50M
Total Bought:
$3.56M
Total Sold:
$1.76M
Net Transaction:
+$1.80M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Entrada Therapeutics, Inc.(TRDA)4,425,7844,425,7840$69.93M$66.79M32.82%-$3.14M
Dyne Therapeutics, Inc.(DYN)4,951,3034,951,3030$44.36M$65.85M32.36%+$21.49M
iTeos Therapeutics, Inc.2,738,7852,738,7850$29.99M$29.99M14.74%$0
Werewolf Therapeutics, Inc.(HOWL)4,284,1724,284,1720$9.17M$16.54M8.13%+$7.37M
Repare Therapeutics, Inc.2,242,6362,242,6360$27.09M$16.37M8.04%-$10.72M
Adaptimmune Therapeutics plcADR(ADAPY)6,287,1015,555,461-731,640$4.90M$4.41M2.16%-$498.5K
Harpoon Therapeutics, Inc.0313,136+313,136$0$3.56M1.75%+$3.56M
Harpoon Therapeutics, Inc.Common313,1360-313,136$1.26M$0—-$1.26M
Page 1 of 1
MPM ASSET MANAGEMENT LLC — 13F Holdings — Q4 2023 | TickerTrail